References
- Alekel DL, Germain AS, Peterson CT, Hanson KB, Stewart JW & Toda T (2000). Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am J Clin Nutr 72:844-852 https://doi.org/10.1093/ajcn/72.3.844
- Ali AA, Velasquez MT, Hansen CT, Mohamed AI & Bhathena SJ (2005). Modulation of carbohydrate metabolism and peptide hormones by soybean isoflavones and probiotics in obesity and diabetes. J Nutr Biochem 16:693-699 https://doi.org/10.1016/j.jnutbio.2005.03.011
- Ali AA, Velasquez MT & Hansen CT (2004). Effects of soy bean isoflavones, probiotics, and their interactions on lipid metabolism and endocrine system in an animal model of obesity and diabetes. J Nutr Biochem 15:583-590 https://doi.org/10.1016/j.jnutbio.2004.04.005
- Anderson JW, Smith BM & Washnock CS (1999). Cardiovascular and renal benefits of dry bean and soybean intake. Am J Clin Nutr 70:464S-474S https://doi.org/10.1093/ajcn/70.3.464s
- Anderson JW, Blake JE, Turner J & Smith BM (1998). Effects of soy protein on renal function and proteinuria in patients with type 2 diabetes. Am J Clin Nutr 68:1347S-1353S https://doi.org/10.1093/ajcn/68.6.1347S
- Aoyama T, Fukui K, Takamatsu K, Hashimoto Y & Yamamoto T (2000). Soy protein isolate and its hydrolysate reduce body fat of dietary obese rats and genetically obese mice (yellow KK). Nutrition 16:349-354 https://doi.org/10.1016/S0899-9007(00)00230-6
- Arjmandi BH, Alekel L, Hollis BW, Amin D, Stacewicz-Sapuntzakis M, Guo P & Kukreja SC (1996). Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr 126:161-167 https://doi.org/10.1093/jn/126.1.161
- Azadbakht L, Shakerhosseini R, Atabak S, Jamshidian M, Mehrabi Y & Esmaill-Zadeh A (2003). Beneficiary effect of dietary soy protein on lowering plasma level lipids and improving kidney function in type II diabetes with nephropathy. Eur J Clin Nutr 57:1292-1294 https://doi.org/10.1038/sj.ejcn.1601688
- Baird DD, Umbach DM, Lansdell L, Hughes CL, Setchell KD, Weinberg CR, Haney AF, Wilcox AJ & Mclachlan JA (1995). Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women. J Clin Endocrinol Metab 80:1685-1690 https://doi.org/10.1210/jc.80.5.1685
- Bartke A, Peluso MR, Moretz N, Wright C, Bonkowski M, Winters TA, Shanahan MF, Kopchick JJ & Banz WJ (2004). Effects of soy-derived diets on plasma and liver lipids, glucose tolerance, and longevity in normal, long-lived and short-lived mice. Horm Meta Res 36:550-558 https://doi.org/10.1055/s-2004-825796
- Bhatena SJ & Velasquez MT (2002). Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr 76:1191-1201 https://doi.org/10.1093/ajcn/76.6.1191
- Bosello O, Cominacini L, Zocca I, Garbin U, Compri R, Davol A & Brunetti L (1998). Short- and long-term effects of hypocaloric diets containing proteins of different sources on plasma lipids and apoproteins of obese subjects. Ann Nutr Metab 32:206-214 https://doi.org/10.1159/000177443
- Chen X & Anderson JJB (2001). Isoflavones inhibit proliferation of ovarian cancer cells in vitro via an estrogen receptor-dependent pathway. Nutr Cancer 41:156-170 https://doi.org/10.1207/S15327914NC41-1&2_22
- Constantinou AI, Lantvit D, Hawthorne M, Xu X, van Breemen RB & Pezzuto JM (2001). Chemopreventive effects of soy protein and purified isoflavones on DMBA-induced mammary tumors in female Sprague-Dawley rats. Nutr Cancer 41:75-81 https://doi.org/10.1207/S15327914NC41-1&2_10
- Duncan AM, Underhill KE, Xu X, Lavalleur J, Phipps WR & Kurzer MS (1999). Modest hormonal effects of soy isoflavones in postmenopausal women. J Clin Endo Metab 84:3479-3484 https://doi.org/10.1210/jc.84.10.3479
- Dyrskog SEU, Jeppesen PB, Colombo M, Abudula R & Hermansen K (2005). Preventive effects of a soy-based diet supplemented with stevioside on the development of the metabolic syndrome and type 2 diabetes in Zucker diabetic fatty rats. Clin Exper 54:1181-1188
- Goodman-Gruen D & Kritz-Silverstein D (2001). Usual dietary isoflavone intake is associated with cardiovascular disease risk factors in postmenopausal women. J Nutr 131:1202-1206
- Hermansen K, Sondergaard M, Hoie L, Carstensen M & Brock B (2001). Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects. Diab Care 24:228-233 https://doi.org/10.2337/diacare.24.2.228
- Hsu CS, Chiu WC & Yeh SH (2003). Effects of soy isoflavone supplementation on plasma glucose, lipids and antioxidant enzyme activities in streptozotocin-induced diabetic rats. Nutr Res 23:67-75 https://doi.org/10.1016/S0271-5317(02)00386-X
- Humphrey LL & Ballard DJ (1990). Renal complications in noninsulin- dependent diabetes mellitus. Clin Ger Med 6, 807-825 https://doi.org/10.1016/S0749-0690(18)30582-2
- Hussain M, Banerjee M, Sarkar FH, Djuric Z, Pollak MN, Doerge D, Fontana J, Chinni S, Davis J, Forman J, Wood DP & Kucuk O (2003). Soy isoflavones in the treatment of prostate cancer. Nutr Cancer 47:111-117 https://doi.org/10.1207/s15327914nc4702_1
- Jenkins DJ, Kendall CW, Jackson CJ, Connelly PW, Parker T, Faulkner D, Vidgen E, Cunnane SC, Leiter LA & Josse RG. (2002). Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. Am J Clin Nutr 76:365-372 https://doi.org/10.1093/ajcn/76.2.365
- Kawano-Takahashi Y, Ohminami H & Okuda I (1986). Effect of soy saponins on thioglucose (GTG) induced obesity in mice. Int J Obes 10:293-302
- Lajolo FM, Hassimotto NMA & Genovese MI (2005). Isoflavone profile and antioxidant activity of Brazilian soybean varieties. Food Sci Technol Int 11:205-211 https://doi.org/10.1177/1082013205054499
- Lavigne C, Marette A & Jacques H (2000). Cod and soy proteins compared with casein improve glucose tolerance and insulin sensitivity in rats. Am J Physiol Endocrinol Metab 278:491-500 https://doi.org/10.1152/ajpendo.2000.278.3.E491
- Lee DS & Lee SH (2001). Genistein, a soy isoflavone, is a potent alpha-glucosidase inhibitor. Fed Eur Biochem Soc letters 501:84-86 https://doi.org/10.1016/S0014-5793(01)02631-X
- Lee JS (2006). Effects of soy protein and genistein on blood glucose, antioxidant enzyme activities, and lipid profile in streptozotocininduced diabetic rats. Life Sci 79:1578-1584 https://doi.org/10.1016/j.lfs.2006.06.030
- Lee SK, Yoon S & Kwon DJ (2000). Estimated isoflavone intake from soy products in Korean middle-aged women. J Korean Soc Food Sci Nutr 29:948-956
- Naaz A, Yellayi S & Zakroczymski MA (2003). The soy isoflavone genistein decreases adipose deposition in mice. Endocrinology 144:3315-3320 https://doi.org/10.1210/en.2003-0076
- Reitman S & Frankel S (1957). A colorimetic method for the determination of serum glutamic oxaloacetic and glutamic pyruvic transaminase. Am J Clin Pathol 2: 56-63
- Ren MQ, Kuhn G, Wegner J & Chen J (2001). Isoflavone, substances with multi-biological and clinical properties. Eur J Nutr 40:135-146 https://doi.org/10.1007/PL00007388
- Ruiz-Larrea MB, Mohan AR, Paganga G., Miller NJ, Bolwell GP & Rice-Evans CA (1997). Antioxidant activity of phytoestrogenic isoflavones. Free Radic Res 26:63-70 https://doi.org/10.3109/10715769709097785
- Satio M (1991). Effect of soy peptides on energy metabolism in obese animals. Nutr Sci Soy Protein 12:91-94
- Setchell KD (2001). Soy isoflavones-benefits and risks from nature's selective estrogen receptor modulators (SERMs). J Am Coll Nutr 20:354S-362S https://doi.org/10.1080/07315724.2001.10719168
- Setchell KD & Cassidy A (1999). Dietary isoflavones: Biological effects and relevance to human health. J Nutr 129:758S-767S https://doi.org/10.1093/jn/129.3.758S
- Somekawa Y, Chiguchi M, Ishibashi T & Aso T (2001). Soy intake related to menopausal symptoms, serum lipids, and bone mineral density in postmenopausal Japanese women. J Obst Gynecol 97: 109-115 https://doi.org/10.1016/S0029-7844(00)01080-2
- Teede HJ, Dalais FS, Kotsopoulos D, Liang YL, Davis S & McGrath BP (2001). Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women. J Clin Endo Metab 86:3053-3060 https://doi.org/10.1210/jc.86.7.3053
- Teixeira SR, Tappenden KA, Carson L, Jones R, Parabhudesai M, Marsl WP & Erdman JW Jr, (2004). Isolated soy protein consumption reduces urinary albumin excretion and improves the serum lipid profile in men with type 2 diabetes mellitus and nephropathy. J Nutr 134:1874-80
- Taha SA & Wasif MM (1996). Hypoglycemic effect and protein nutritive quality of soy and methionine supplemented whole durum pasta products. Nahrung 40:281-287 https://doi.org/10.1002/food.19960400512
- Tham DM, Gardner CD & Haskell WL (1998). Potential health benefits of dietary phytoestrogens: A review of the clinical, epidemiological, and mechanistic evidence. J Clin Endo Metab 83:2223-2235 https://doi.org/10.1210/jc.83.7.2223
- Upmalis DH, Lobo R, Bradley L, Warren M, Cone FL & Lamia CA (2000). Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: A multicenter, double-blind, randomized, placebo-controlled study. Menopause 7:236-242 https://doi.org/10.1097/00042192-200007040-00005
- Vedavanam K, Srijayanta S, O'Reilly J, Raman A & Wiseman H (1999). Antioxidant action and potential antidiabetic properties of an isoflavonoid-containing soyabean phytochemical extract (SPE). Phyto Res 13:601-608 https://doi.org/10.1002/(SICI)1099-1573(199911)13:7<601::AID-PTR550>3.0.CO;2-O
- Wang HJ & Murphy PA (1994). Isoflavone content in commercial soybean foods. J Agric Food Chem 42:1666-1673 https://doi.org/10.1021/jf00044a016
- Washburn S, Burke GL, Morgan T & Anthony M (1999). Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in premenopausal women. In B,G, Wrem (Ed.), Menopause 6:7-13
- Wei H, Bowen R, Cai Q, Barnes S & Wang Y (1995). Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc Soc Exp Biol Med 208:124-130
- Yamashita T, Sasahara T, Pomeroy SE, Collier G. & Nestel PG (1998). Arterial compliance, blood pressure, plasma leptin, and plasma lipids in women are improved with weight reduction equally with a meat-based diet and a plant-based diet. Metabolism 47:1308-1314 https://doi.org/10.1016/S0026-0495(98)90297-9
- Zhang M, Xie X, Lee AH & Binns CW (2004). Soy isoflavone intake are associated with reduced risk of ovarian cancer in southeast China. Nutr Cancer 49:125-130 https://doi.org/10.1207/s15327914nc4902_2